These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21943108)

  • 21. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.
    Shi L; Zhao M; Abbey CA; Tsai SH; Xie W; Pham D; Chapman S; Bayless KJ; Hein TW; Rosa RH; Ko ML; Kuo L; Ko GY
    J Am Heart Assoc; 2019 Nov; 8(22):e013673. PubMed ID: 31698979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer.
    Lee SJ; Lee I; Lee J; Park C; Kang WK
    Br J Cancer; 2014 Jul; 111(3):497-505. PubMed ID: 24945998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.
    Kim BH; Lee J; Choi JS; Park DY; Song HY; Park TK; Cho CH; Ye SK; Joo CK; Koh GY; Kim TY
    Br J Pharmacol; 2015 Aug; 172(15):3875-89. PubMed ID: 25917462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G; Sun L; Pei Y; Wang D
    Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide Inhibits Angiogenesis via Downregulation of VEGF and Angiopoietin-2 in Crohn's Disease.
    Wang L; Wang S; Xue A; Shi J; Zheng C; Huang Y
    Inflammation; 2021 Apr; 44(2):795-807. PubMed ID: 33206273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4.
    Su M; Huang J; Liu S; Xiao Y; Qin X; Liu J; Pi C; Luo T; Li J; Chen X; Luo Z
    Sci Rep; 2016 Jun; 6():28139. PubMed ID: 27338725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development.
    Thapa K; Khan H; Kaur G; Kumar P; Singh TG
    Biochem Biophys Res Commun; 2023 Dec; 687():149130. PubMed ID: 37944468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model.
    Burkholder TP; Clayton JR; Rempala ME; Henry JR; Knobeloch JM; Mendel D; McLean JA; Hao Y; Barda DA; Considine EL; Uhlik MT; Chen Y; Ma L; Bloem LJ; Akunda JK; McCann DJ; Sanchez-Felix M; Clawson DK; Lahn MM; Starling JJ
    Invest New Drugs; 2012 Jun; 30(3):936-49. PubMed ID: 21360050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization.
    Lin W; Tu H; Zhu Y; Guan Y; Liu H; Ling W; Yan P; Dong J
    Phytomedicine; 2019 Nov; 64():152923. PubMed ID: 31450226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
    Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
    Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.
    Rezzola S; Paganini G; Semeraro F; Presta M; Tobia C
    Biochim Biophys Acta; 2016 Jul; 1862(7):1291-6. PubMed ID: 27085972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models.
    Cicatiello V; Apicella I; Tudisco L; Tarallo V; Formisano L; Sandomenico A; Kim Y; Bastos-Carvalho A; Orlandi A; Ambati J; Ruvo M; Bianco R; De Falco S
    Oncotarget; 2015 Apr; 6(12):10563-76. PubMed ID: 25868854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects.
    Bakri SJ; Lynch J; Howard-Sparks M; Saint-Juste S; Saim S
    PLoS One; 2024; 19(6):e0304782. PubMed ID: 38833447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.
    Huang H; Lai JY; Do J; Liu D; Li L; Del Rosario J; Doppalapudi VR; Pirie-Shepherd S; Levin N; Bradshaw C; Woodnutt G; Lappe R; Bhat A
    Clin Cancer Res; 2011 Mar; 17(5):1001-11. PubMed ID: 21233403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.